LabCompass

Julianna Roddy

Medicine · The Ohio State University

Established · publishing since 1994

Publications

44

Citations

583

Est. group size

Recurring co-author estimate

Active years

32

Publishing since 1994

Research summary
AI-generated

Julianna Roddy's work focuses on the clinical pharmacy aspects of blood cancer treatment, particularly hematopoietic stem cell (bone marrow) transplantation and cellular therapies like CAR-T cell therapy. Publications cover medication management, safety, and toxicity for patients undergoing these treatments, as well as related topics such as pharmacy education and practice guidelines. The work is largely clinical and practice-oriented rather than basic laboratory research.

Hematopoietic stem cell transplantation pharmacy careCAR-T cell therapy management and toxicityAcute myeloid leukemia treatmentClinical pharmacy practice and educationMedication safety in cancer care

Publication output peaked around 2020 with a burst of activity (including several COVID-19-related position statements) but has generally slowed and become more sporadic in recent years, averaging about 1.4 publications per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
2017: 2 publications172018: 3 publications182019: 4 publications192020: 9 publications9202021: 2 publications212022: 2 publications222023: 1 publication232024: 3 publications242025: 1 publication2526
Recent publications
Publishes in
  • Biology of Blood and Marrow Transplantation×5
  • Leukemia & lymphoma/Leukemia and lymphoma×4
  • Blood×4
  • Clinical Lymphoma Myeloma & Leukemia×3
  • Bone Marrow Transplantation×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile